| Name | Title | Contact Details |
|---|
Cantox U.S. is a Bridgewater, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Musceltech is a Elliot Lake, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Carman Oaks is a Lake Oswego, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CompuGroup Medical is a global eHealth provider with a comprehensive portfolio of cutting-edge IT solutions for the healthcare industry. Our Meaningful Use and ICD-10 enabled products allow users to securely store, exchange and access important clinical and financial insight anytime and anywhere. We connect doctors, hospitals, community health facilities, dentists, pharmacists, health insurers and other service providers to create an integrated network of all healthcare stakeholders. As a result, we can help these organizations improve efficiency, optimize care and increase patient satisfaction while also improving profitability. Our market-leading solutions include everything from electronic health records to innovative practice management systems. These solutions are present in over 400,000 practices and healthcare organizations worldwide. We are also proud to maintain and sustain long-term relationships with our clients, many of whom have been using our products for decades. Our dedicated, knowledgeable team consistently delivers innovative products and services with the customer in mind, knowing that in addition to running an effective business, their main focus is to heal the patient. We share that same passion and it drives everything we do. As an owner-led and publicly traded company, CGM uniquely combines the personal touch of a local business with the strength of a global entity. We are committed to meeting and exceeding our clients` expectations, and our goal is to become the #1 choice for all healthcare providers in the United States – a position we have already achieved in many other countries around the world.
For decades, entrenched infrastructure barriers have slowed progress in the fight against cancer and the development of potent immunotherapies. The Parker Institute for Cancer Immunotherapy breaks down these barriers. The result is groundbreaking new research and an intellectual property model that builds collaboration between researchers, nonprofits and industry all working together to get treatments to patients faster.